Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues-Reference-Cited by-同舟云学术

Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues

Published:2007-01 Issue:2 Volume:15 Page:702-713
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Ahn Yu Mi,Vogeti Lakshminarayana,Liu Chun-Jing,Santhapuram Hari K.R.,White Jonathan M.,Vasandani Veena,Mitscher Lester A.,Lushington Gerald H.,Hanson Paul R.,Powell Douglas R.,Himes Richard H.,Roby Katherine F.,Ye Qizhuang,Georg Gunda I.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference44 articles.

1. Inhibitors of Cyclin-Dependent Kinases as Anti-Cancer Therapeutics

2. Cyclin-Dependent Kinases

3. Protein kinases — the major drug targets of the twenty-first century?

4. Targeting hyperproliferative disorders with cyclin dependent kinase inhibitors

5. Inhibition of CDKs as a Therapeutic Modality

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pharmacological Implications of Flavopiridol: An Updated Overview;Molecules;2023-11-10

2. Exploring the potential of chromone scaffold compounds in cancer therapy: targeting key kinase pathways;Medicinal Chemistry Research;2023-04-20

3. “Molecular docking and dynamics study of Acetogenins targeting cyclin-dependent kinase and in-vitro evaluation of Annona muricata fruit extracts using MDA-MB-231 breast cancer cell line”;Letters in Drug Design & Discovery;2023-02-02

4. Novel benzo chromene derivatives: design, synthesis, molecular docking, cell cycle arrest, and apoptosis induction in human acute myeloid leukemia HL-60 cells;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-12-02

5. Recent Insights into Therapeutic Potential of Plant-Derived Flavonoids against Cancer;Anti-Cancer Agents in Medicinal Chemistry;2022-12